期刊文献+

喜脑宁对局灶性脑缺血再灌注损伤的保护作用及机制 被引量:2

Protective effects of Xinaoning on focal cerebral ischemia/reperfusion injury and its mechanism of action
原文传递
导出
摘要 目的:探讨喜脑宁对脑缺血再灌注损伤的保护作用及其机制。方法:采用大鼠线栓法制备脑缺血再灌注模型,观察喜脑宁对神经功能评分、脑梗死体积和脑组织病理形态学变化的影响,电镜观察脑组织超微结构,免疫组化检测肿瘤坏死因子-α的表达。结果:喜脑宁(12,24g.kg-1)可降低脑缺血再灌注后的神经功能评分和脑梗死体积,改善脑组织病理形态学和超微结构,抑制脑组织肿瘤坏死因子-α的表达。结论:喜脑宁对脑缺血再灌注损伤具有一定的保护作用,其机制可能与抑制肿瘤坏死因子α的表达有关。 OBJECTIVE To study the protective effects of Xinaoning (XNN) on focal cerebral ischemia/reperfusion injury and to explore its mechanism of action. METHODS Middle cerebral artery occlusion (MCAO) was used to make focal cerebral ischemia/reperfusion model by intravascular nylon filamentocclusion. The protective effects of XNN at different doses were evaluated by investigating neurological function score, infarct volume of brain, patbomorphological changes of brain, the ultrastructure of neuron, expression of tumor necrosis factor-α. RESULTS Compared with model group, XNN (12, 24 g·kg^-1 ) could decrease the neurological score and infarct volume, improve pathomorphology and neuron ultrastructure of brain, inhibit the expression of TNF-α. CONCLUSION XNN has protective effects on focal cerebral ischemia/reperfusion injury. The role of inhibiting the expression of TNF-α contributes to its neuroprotective effects.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2010年第13期1120-1123,共4页 Chinese Journal of Hospital Pharmacy
关键词 脑缺血再灌注损伤 肿瘤坏死因子Α cerebral ischemia/reperfusion injury TNF-α
作者简介 尹艳艳,女,博士,副教授,硕士生导师,电话:0551-5161133,Email:yinyanyan5678@126.com
  • 相关文献

参考文献1

二级参考文献1

  • 1I. M. Skogseid,H. K. Nordby,P. Urdal,E. Paus,F. Lilleaas.Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage[J].Acta Neurochirurgica (-).1992(3-4)

共引文献11

同被引文献26

  • 1张敬军.重组人粒细胞集落刺激因子在神经系统的应用研究[J].中国现代药物应用,2007,1(11):96-98. 被引量:7
  • 2李永胜,王进,王照华,冯俊,梁黔生,郑智.丹参酮ⅡA对主动脉内皮细胞功能损伤的保护机制[J].中国急救医学,2007,27(8):720-723. 被引量:36
  • 3Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats [J]. Stroke, 1989,20(1 ) :84-91.
  • 4王丁超,刘敬霞,张新峰,田玉收,李建生.骨髓干细胞动员治疗脑缺血损伤[J].中国组织工程研究与临床康复,2007,11(46):9365-9368. 被引量:5
  • 5Dictz AB,Padley DJ,Gastineau DA. Infrastructure development for human cell therapy translation[J].{H}Clinical Pharmacology & Therapeutics,2007,(03):320-323.
  • 6Ruster B,Gottig S,Ludwig RJ. Mesenchymal stem cells (MSCs) display coordinated rolling and adhesion behavior on endothelial cells[J].{H}Blood,2006,(12):3938-3944.
  • 7Komine-Kobayashi M,Zhang N,Liu M. Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice[J].{H}Journal of Cerebral Blood Flow and Metabolism,2006,(03):402-413.
  • 8Kollmar R,Henninger N,Urbanek C. G-CSF,rt-PA and combination therapy after experimental thromboembolic stroke[J].Exp Transl Stroke Med,2010,(02):9.
  • 9Xie J,Wang H,Song T. Tanshinone ⅡA and astragaloside Ⅳ promote the migration of mesenchymal stem cells by up-regulation of CXCR4[J].{H}PROTOPLASMA,2013,(02):521-530.
  • 10武继彪,隋在云,管华诗.丹皮酚对大鼠脑缺血再灌注损伤的保护作用[J].中华中医药学刊,2008,26(9):1887-1888. 被引量:21

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部